Spy-C Mouse Model for Rapid cMyBP-C Protein Exchange

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods are inadequate for rapidly replacing cardiac myosin binding protein-C (cMyBP-C) in sarcomeres, hindering the study of its function, phosphorylation sites, and the effects of mutations, due to complex dynamic interactions and difficulties in manipulating large muscle filaments.

Innovation Solution

A gene-edited mouse model platform using a Spy-C mouse model with a protease recognition site and SpyTag peptide allows for the rapid exchange of modified or mutant cMyBP-C proteins, enabling their introduction into sarcomeres with precise modifications and functional studies.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional AAV or adenoviral methods are used to manipulate cMyBP-C, then some level of protein delivery is achieved, but the replacement efficiency is limited and manipulation of large thick filaments remains difficult

Engineering Contradiction:
ImprovecMyBP-C replacement efficiencyVSAvoidcomplexity of manipulation procedures
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The cMyBP-C protein is divided into two functional segments: the N-terminal domain (C0-C7) that can be rapidly exchanged and the C-terminal domain (C8-C10) that anchors to the thick filament. This segmentation allows the stable C-terminal portion to remain while the N-terminal portion is replaced using the SpyCatcher-SpyTag system, achieving efficient manipulation without requiring replacement of the entire protein.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The SpyCatcher-SpyTag peptide pair serves as an intermediary mechanism enabling specific covalent bonding between the introduced recombinant cMyBP-C and the endogenous cMyBP-C scaffold. This intermediary system facilitates precise protein replacement at the molecular level, overcoming the limitations of traditional viral delivery methods.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If in vitro assays are used to study cMyBP-C, then some experimental control is achieved, but the unique localization of cMyBP-C within the sarcomere is not preserved and partial fragments are used in excess

Engineering Contradiction:
Improveexperimental controlVSAvoidphysiological relevance
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The Spy-C mouse model is pre-engineered with the SpyTag peptide inserted into the cMyBP-C gene at the C7-C8 domain junction. This preliminary genetic modification allows for rapid and specific replacement of the N-terminal domain in vivo, preserving the protein's native sarcomeric localization and physiological context while enabling experimental manipulation.

Inventive Principle:
Principle #10Preliminary action

3Loss of information

If cMyBP-C is studied using current methods, then some functional analysis is possible, but the complex dynamic interactions with binding partners make the study extremely complex and time-consuming

Engineering Contradiction:
Improvefunctional understandingVSAvoidresearch time required
Core Design Contradiction:
Loss of informationVSLoss of time

Solution Approach 1:

The invention applies modifications at specific local regions of the cMyBP-C protein (N-terminal domains C0-C7) while leaving the C-terminal anchoring domains (C8-C10) unchanged. This localized approach allows functional studies of specific domains without disrupting the overall protein structure or its interactions with thick filament binding partners, thereby reducing experimental complexity.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the rapid introduction of genetic modifications to cMyBP-C in its native position, facilitating the study of its function and disease-related mutations, and provides a platform for modifying other sarcomeric proteins, enhancing research and drug screening capabilities.

Implementation Method 1

The protease recognition site allows the cMyBP-C protein to be cleaved to eliminate the N-Terminus

Methodology Applied
Scientific EffectProtease recognition and cleavage: Enzyme

Implementation Method 2

the SpyTag peptide allows a different peptide to be attached to the remaining portion of cMyBP-C

Methodology Applied
Scientific EffectSpyTag-SpyCatcher binding: Chemical Bonding

Data Source

PatentUS11242368B2Methods and compositions for rapidly replacing cardiac myosin binding protein-C in sarcomeres
Publication Date: 2022.02.08 THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZONA
  • US11242368B2 patent drawing
  • US11242368B2 patent drawing

AI summary

Methods and compositions for rapidly replacing cMyBP-C in sarcomeres featuring the creation of Spy-C mice, which are mice genetically engineered to express cMyBP-C with a protease recognition site and SpyTag peptide introduced into the cMyBP-C gene. In permeabilized myocytes from the Spy-C mice, the cMyBP-C protein can be cleaved at the protease recognition site, and the N-Terminus of cMyBP-C can be removed while the C-terminus remains anchored to the thick filament. A new peptide featuring the SpyCatcher sequence can be covalently bonded to the remaining portion of cMyBP-C, thereby creating a modified cMyBP-C protein. The methods and compositions of the present invention allow for the reconstitution of full-length cMyBP-C at the precise position of native cMyBP-C in the sarcomere and allow for a variety of modifications to be introduced to cMyBP-C in situ.